Apollo Hospitals Enterprise Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: February 10, 2026, 8:24 pm

Market Cap	1,03,794 Cr.
Current Price	7,219
Intrinsic Value	₹6,289.40
High / Low	8,100/6,001
Stock P/E	57.2
Book Value	632
Dividend Yield	0.26 %
ROCE	16.6 %
ROE	18.4 %
Face Value	5.00
PEG Ratio	5.94

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Apollo Hospitals Enterprise Ltd

Competitors

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
NG Industries Ltd	48.2 Cr.	144	187/120		117	2.43 %	23.6 %	20.7 %	10.0
Global Longlife Hospital and Research Ltd	13.5 Cr.	12.8	33.0/12.8		24.3	0.00 %	13.7 %	17.7 %	10.0
Gian Lifecare Ltd	10.2 Cr.	9.89	20.5/7.08		18.7	0.00 %	3.00 %	0.81 %	10.0
Fortis Malar Hospitals Ltd	105 Cr.	55.8	98.7/52.2	23.0	18.3	0.00 %	0.83 %	0.56 %	10.0
Family Care Hospitals Ltd	19.3 Cr.	3.58	6.12/3.28		1.51	0.00 %	79.2 %	85.5 %	10.0
Industry Average	25,758.00 Cr	691.23		95.15	92.86	0.34%	15.48%	14.81%	9.04

All Competitor Stocks of Apollo Hospitals Enterprise Ltd

Quarterly Result

Metric	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Sales	4,251	4,264	4,302	4,418	4,847	4,851	4,944	5,086	5,589	5,527	5,592	5,842	6,304
Expenses	3,699	3,780	3,814	3,909	4,219	4,237	4,303	4,410	4,774	4,765	4,822	4,990	5,362
Operating Profit	552	484	488	509	628	614	640	675	816	762	770	852	941
OPM %	13%	11%	11%	12%	13%	13%	13%	13%	15%	14%	14%	15%	15%
Other Income	23	35	20	34	26	29	37	49	44	69	72	54	61
Interest	93	100	95	106	111	113	119	116	118	110	115	108	110
Depreciation	155	153	159	167	163	167	190	177	184	185	211	215	218
Profit before tax	327	266	254	270	379	363	368	430	557	536	516	583	675
Tax %	35%	39%	43%	36%	34%	30%	30%	27%	29%	29%	20%	24%	27%
Net Profit	213	162	146	173	249	254	258	316	396	379	414	441	494
EPS in Rs	14.19	10.68	10.05	11.59	16.20	17.06	17.65	21.23	26.34	25.89	27.10	30.10	33.19

Last Updated: January 2, 2026, 11:30 am

Below is a detailed analysis of the quarterly data for Apollo Hospitals Enterprise Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

For Sales, as of Sep 2025, the value is 6,304.00 Cr.. The value appears strong and on an upward trend. It has increased from 5,842.00 Cr. (Jun 2025) to 6,304.00 Cr., marking an increase of 462.00 Cr..
For Expenses, as of Sep 2025, the value is 5,362.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4,990.00 Cr. (Jun 2025) to 5,362.00 Cr., marking an increase of 372.00 Cr..
For Operating Profit, as of Sep 2025, the value is 941.00 Cr.. The value appears strong and on an upward trend. It has increased from 852.00 Cr. (Jun 2025) to 941.00 Cr., marking an increase of 89.00 Cr..
For OPM %, as of Sep 2025, the value is 15.00%. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 15.00%.
For Other Income, as of Sep 2025, the value is 61.00 Cr.. The value appears strong and on an upward trend. It has increased from 54.00 Cr. (Jun 2025) to 61.00 Cr., marking an increase of 7.00 Cr..
For Interest, as of Sep 2025, the value is 110.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 108.00 Cr. (Jun 2025) to 110.00 Cr., marking an increase of 2.00 Cr..
For Depreciation, as of Sep 2025, the value is 218.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 215.00 Cr. (Jun 2025) to 218.00 Cr., marking an increase of 3.00 Cr..
For Profit before tax, as of Sep 2025, the value is 675.00 Cr.. The value appears strong and on an upward trend. It has increased from 583.00 Cr. (Jun 2025) to 675.00 Cr., marking an increase of 92.00 Cr..
For Tax %, as of Sep 2025, the value is 27.00%. The value appears to be increasing, which may not be favorable. It has increased from 24.00% (Jun 2025) to 27.00%, marking an increase of 3.00%.
For Net Profit, as of Sep 2025, the value is 494.00 Cr.. The value appears strong and on an upward trend. It has increased from 441.00 Cr. (Jun 2025) to 494.00 Cr., marking an increase of 53.00 Cr..
For EPS in Rs, as of Sep 2025, the value is 33.19. The value appears strong and on an upward trend. It has increased from 30.10 (Jun 2025) to 33.19, marking an increase of 3.09.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: December 15, 2025, 5:39 am

Metric	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	4,357	5,129	6,150	7,256	8,243	9,617	11,247	10,560	14,663	16,612	19,059	21,794	23,265
Expenses	3,681	4,392	5,465	6,522	7,442	8,548	9,656	9,420	12,474	14,548	16,665	18,761	19,940
Operating Profit	676	737	684	734	801	1,070	1,591	1,140	2,189	2,065	2,394	3,033	3,324
OPM %	16%	14%	11%	10%	10%	11%	14%	11%	15%	12%	13%	14%	14%
Other Income	18	47	92	60	24	26	222	103	368	75	123	222	256
Interest	119	118	180	257	295	327	533	449	379	381	449	458	442
Depreciation	168	212	264	314	359	396	620	573	601	615	687	758	828
Profit before tax	407	455	332	222	171	373	660	221	1,578	1,144	1,380	2,039	2,309
Tax %	25%	29%	29%	41%	65%	47%	34%	38%	30%	22%	32%	26%
Net Profit	315	335	235	131	60	200	432	137	1,108	844	935	1,505	1,729
EPS in Rs	22.77	24.43	16.99	15.88	8.44	16.96	32.70	10.46	73.42	56.97	62.50	100.56	116.28
Dividend Payout %	25%	24%	35%	38%	59%	35%	18%	29%	16%	26%	26%	13%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2014-2015	2015-2016	2016-2017	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024	2024-2025
YoY Net Profit Growth (%)	6.35%	-29.85%	-44.26%	-54.20%	233.33%	116.00%	-68.29%	708.76%	-23.83%	10.78%	60.96%
Change in YoY Net Profit Growth (%)	0.00%	-36.20%	-14.40%	-9.94%	287.53%	-117.33%	-184.29%	777.05%	-732.59%	34.61%	50.18%

Apollo Hospitals Enterprise Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:	16%
5 Years:	14%
3 Years:	14%
TTM:	14%

Compounded Profit Growth
10 Years:	16%
5 Years:	34%
3 Years:	18%
TTM:	52%

Stock Price CAGR
10 Years:	20%
5 Years:	37%
3 Years:	23%
1 Year:	14%

Return on Equity
10 Years:	11%
5 Years:	14%
3 Years:	15%
Last Year:	18%

Last Updated: September 4, 2025, 11:25 pm

Balance Sheet

Last Updated: December 4, 2025, 12:57 am

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Sep 2025
Equity Capital	70	70	70	70	70	70	70	72	72	72	72	72	72
Reserves	2,907	3,102	3,262	3,244	3,182	3,264	3,270	4,531	5,551	6,126	6,864	8,140	9,021
Borrowings	1,344	1,992	2,834	3,125	3,427	3,673	3,596	4,160	4,068	4,332	5,333	7,864	7,987
Other Liabilities	1,029	1,296	1,195	1,665	1,917	2,159	4,354	2,629	3,570	3,886	4,474	4,568	4,870
Total Liabilities	5,350	6,459	7,360	8,103	8,596	9,166	11,289	11,392	13,261	14,416	16,742	20,644	21,950
Fixed Assets	2,681	3,244	3,997	4,591	4,773	4,982	7,432	6,778	8,296	8,520	9,664	10,988	11,262
CWIP	491	533	562	347	712	822	236	234	46	610	873	921	1,026
Investments	322	311	352	406	352	462	434	1,343	816	574	986	2,487	3,008
Other Assets	1,855	2,372	2,448	2,759	2,759	2,901	3,187	3,037	4,104	4,712	5,219	6,248	6,653
Total Assets	5,350	6,459	7,360	8,103	8,596	9,166	11,289	11,392	13,261	14,416	16,742	20,644	21,950

Below is a detailed analysis of the balance sheet data for Apollo Hospitals Enterprise Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

For Equity Capital, as of Sep 2025, the value is 72.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 72.00 Cr..
For Reserves, as of Sep 2025, the value is 9,021.00 Cr.. The value appears strong and on an upward trend. It has increased from 8,140.00 Cr. (Mar 2025) to 9,021.00 Cr., marking an increase of 881.00 Cr..
For Borrowings, as of Sep 2025, the value is 7,987.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 7,864.00 Cr. (Mar 2025) to 7,987.00 Cr., marking an increase of 123.00 Cr..
For Other Liabilities, as of Sep 2025, the value is 4,870.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4,568.00 Cr. (Mar 2025) to 4,870.00 Cr., marking an increase of 302.00 Cr..
For Total Liabilities, as of Sep 2025, the value is 21,950.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 20,644.00 Cr. (Mar 2025) to 21,950.00 Cr., marking an increase of 1,306.00 Cr..
For Fixed Assets, as of Sep 2025, the value is 11,262.00 Cr.. The value appears strong and on an upward trend. It has increased from 10,988.00 Cr. (Mar 2025) to 11,262.00 Cr., marking an increase of 274.00 Cr..
For CWIP, as of Sep 2025, the value is 1,026.00 Cr.. The value appears strong and on an upward trend. It has increased from 921.00 Cr. (Mar 2025) to 1,026.00 Cr., marking an increase of 105.00 Cr..
For Investments, as of Sep 2025, the value is 3,008.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,487.00 Cr. (Mar 2025) to 3,008.00 Cr., marking an increase of 521.00 Cr..
For Other Assets, as of Sep 2025, the value is 6,653.00 Cr.. The value appears strong and on an upward trend. It has increased from 6,248.00 Cr. (Mar 2025) to 6,653.00 Cr., marking an increase of 405.00 Cr..
For Total Assets, as of Sep 2025, the value is 21,950.00 Cr.. The value appears strong and on an upward trend. It has increased from 20,644.00 Cr. (Mar 2025) to 21,950.00 Cr., marking an increase of 1,306.00 Cr..

Notably, the Reserves (9,021.00 Cr.) exceed the Borrowings (7,987.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity +	373	470	597	623	537	905	1,293	1,265	1,696	1,377	1,920	2,136
Cash from Investing Activity +	-356	-759	-888	-1,152	-405	-711	-289	-880	-747	-857	-1,537	-3,381
Cash from Financing Activity +	-63	392	330	477	-108	-215	-910	-340	-792	-633	-311	1,317
Net Cash Flow	-46	103	39	-52	24	-20	94	44	158	-113	72	73

Free Cash Flow

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Free Cash Flow	675.00	736.00	682.00	731.00	798.00	-2.00	-2.00	-3.00	-2.00	-2.00	-3.00	-4.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Debtor Days	44	43	36	38	37	39	33	46	44	49	48	51
Inventory Days	47	50	49	47	51	46	49	16	21	17	17	16
Days Payable	55	59	66	51	55	56	60	74	79	82	88	72
Cash Conversion Cycle	36	34	19	34	33	29	22	-12	-14	-16	-23	-6
Working Capital Days	23	24	16	27	8	-3	-8	-4	5	-1	-19	-6
ROCE %	12%	12%	9%	8%	7%	10%	14%	8%	17%	14%	15%	17%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Promoters	29.33%	29.33%	29.33%	29.33%	29.33%	29.33%	29.33%	29.33%	29.33%	29.34%	29.34%	28.02%
FIIs	47.94%	46.96%	47.93%	46.15%	46.25%	45.63%	43.92%	45.37%	45.27%	42.74%	43.49%	44.20%
DIIs	16.56%	17.76%	17.02%	18.59%	18.87%	19.55%	21.13%	19.94%	19.97%	22.29%	21.34%	21.12%
Government	0.23%	0.23%	0.23%	0.23%	0.23%	0.23%	0.23%	0.23%	0.23%	0.23%	0.23%	0.23%
Public	5.94%	5.72%	5.49%	5.68%	5.32%	5.26%	5.38%	5.12%	5.21%	5.41%	5.61%	6.43%
No. of Shareholders	1,31,636	1,31,937	1,20,030	1,31,565	1,19,578	1,30,664	1,27,754	1,19,245	1,27,802	1,34,058	1,41,007	1,60,556

Shareholding Pattern Chart

No. of Shareholders

Apollo Hospitals Enterprise Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

Mutual Fund Holdings

Fund Name	No of Shares	AUM (%)	Amount Invested (Cr)	Previous Number of Shares	Previous Date	Percentage Change
Axis Large Cap Fund	982,831	2.06	692.16	919,526	2026-01-25 12:22:33	6.88%
Mirae Asset Large Cap Fund	804,081	1.35	566.27	777,300	2026-01-25 18:24:08	3.45%
Invesco India Contra Fund	696,469	2.37	490.49	711,861	2026-01-25 02:12:33	-2.16%
Mirae Asset Large & Midcap Fund	684,370	1.1	481.97	538,597	2026-01-25 06:22:29	27.07%
Axis Focused Fund	668,123	3.93	470.53	N/A	N/A	N/A
HDFC Flexi Cap Fund	650,000	0.48	457.76	N/A	N/A	N/A
Nippon India Pharma Fund	648,795	5.53	456.91	648,795	2025-04-22 17:25:42	0%
Mirae Asset ELSS Tax Saver Fund	640,797	1.66	451.28	558,951	2026-01-25 15:15:04	14.64%
Franklin India Flexi Cap Fund	591,846	2.09	416.81	N/A	N/A	N/A
Aditya Birla Sun Life Large Cap Fund	465,347	1.04	327.72	N/A	N/A	N/A

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
FaceValue	5.00	5.00	5.00	5.00	5.00
Basic EPS (Rs.)	100.56	62.50	56.97	73.42	10.74
Diluted EPS (Rs.)	100.56	62.50	56.97	73.42	10.74
Cash EPS (Rs.)	155.05	111.54	104.51	118.34	49.31
Book Value[Excl.RevalReserv]/Share (Rs.)	571.09	509.07	454.19	408.74	333.96
Book Value[Incl.RevalReserv]/Share (Rs.)	571.09	509.07	454.19	408.74	333.96
Revenue From Operations / Share (Rs.)	1515.58	1325.40	1155.25	1019.65	734.35
PBDIT / Share (Rs.)	224.07	173.64	148.81	157.39	82.22
PBIT / Share (Rs.)	171.39	125.87	106.02	115.62	42.37
PBT / Share (Rs.)	139.51	94.75	79.53	109.74	15.35
Net Profit / Share (Rs.)	102.37	63.77	61.72	76.57	9.46
NP After MI And SOA / Share (Rs.)	100.55	62.49	56.96	73.41	10.46
PBDIT Margin (%)	14.78	13.10	12.88	15.43	11.19
PBIT Margin (%)	11.30	9.49	9.17	11.33	5.76
PBT Margin (%)	9.20	7.14	6.88	10.76	2.08
Net Profit Margin (%)	6.75	4.81	5.34	7.50	1.28
NP After MI And SOA Margin (%)	6.63	4.71	4.93	7.19	1.42
Return on Networth / Equity (%)	17.60	12.95	13.21	18.77	3.26
Return on Capital Employeed (%)	15.32	14.97	13.73	15.38	6.49
Return On Assets (%)	6.99	5.36	5.67	8.00	1.31
Long Term Debt / Equity (X)	0.53	0.32	0.31	0.43	0.53
Total Debt / Equity (X)	0.64	0.45	0.43	0.46	0.54
Asset Turnover Ratio (%)	1.17	1.22	0.54	0.55	0.86
Current Ratio (X)	1.53	1.13	1.30	1.73	1.79
Quick Ratio (X)	1.43	1.03	1.19	1.55	1.66
Inventory Turnover Ratio (X)	46.34	0.00	0.00	0.00	0.00
Dividend Payout Ratio (NP) (%)	18.89	24.00	31.15	4.13	25.46
Dividend Payout Ratio (CP) (%)	12.39	13.60	17.79	2.63	5.29
Earning Retention Ratio (%)	81.11	76.00	68.85	95.87	74.54
Cash Earning Retention Ratio (%)	87.61	86.40	82.21	97.37	94.71
Interest Coverage Ratio (X)	7.03	5.56	5.62	5.98	2.63
Interest Coverage Ratio (Post Tax) (X)	4.21	3.04	3.33	3.13	1.17
Enterprise Value (Cr.)	99584.27	93953.52	64237.57	66797.88	43713.80
EV / Net Operating Revenue (X)	4.57	4.93	3.87	4.56	4.14
EV / EBITDA (X)	30.91	37.63	30.02	29.51	36.97
MarketCap / Net Operating Revenue (X)	4.37	4.79	3.73	4.43	3.95
Retention Ratios (%)	81.10	75.99	68.84	95.86	74.53
Price / BV (X)	11.60	13.17	10.00	11.55	9.07
Price / Net Operating Revenue (X)	4.37	4.79	3.73	4.43	3.95
EarningsYield	0.01	0.01	0.01	0.01	0.00

After reviewing the key financial ratios for Apollo Hospitals Enterprise Ltd, here is a detailed analysis based on the latest available data and recent trends:

For FaceValue, as of Mar 25, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 5.00.
For Basic EPS (Rs.), as of Mar 25, the value is 100.56. This value is within the healthy range. It has increased from 62.50 (Mar 24) to 100.56, marking an increase of 38.06.
For Diluted EPS (Rs.), as of Mar 25, the value is 100.56. This value is within the healthy range. It has increased from 62.50 (Mar 24) to 100.56, marking an increase of 38.06.
For Cash EPS (Rs.), as of Mar 25, the value is 155.05. This value is within the healthy range. It has increased from 111.54 (Mar 24) to 155.05, marking an increase of 43.51.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 571.09. It has increased from 509.07 (Mar 24) to 571.09, marking an increase of 62.02.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 571.09. It has increased from 509.07 (Mar 24) to 571.09, marking an increase of 62.02.
For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 1,515.58. It has increased from 1,325.40 (Mar 24) to 1,515.58, marking an increase of 190.18.
For PBDIT / Share (Rs.), as of Mar 25, the value is 224.07. This value is within the healthy range. It has increased from 173.64 (Mar 24) to 224.07, marking an increase of 50.43.
For PBIT / Share (Rs.), as of Mar 25, the value is 171.39. This value is within the healthy range. It has increased from 125.87 (Mar 24) to 171.39, marking an increase of 45.52.
For PBT / Share (Rs.), as of Mar 25, the value is 139.51. This value is within the healthy range. It has increased from 94.75 (Mar 24) to 139.51, marking an increase of 44.76.
For Net Profit / Share (Rs.), as of Mar 25, the value is 102.37. This value is within the healthy range. It has increased from 63.77 (Mar 24) to 102.37, marking an increase of 38.60.
For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 100.55. This value is within the healthy range. It has increased from 62.49 (Mar 24) to 100.55, marking an increase of 38.06.
For PBDIT Margin (%), as of Mar 25, the value is 14.78. This value is within the healthy range. It has increased from 13.10 (Mar 24) to 14.78, marking an increase of 1.68.
For PBIT Margin (%), as of Mar 25, the value is 11.30. This value is within the healthy range. It has increased from 9.49 (Mar 24) to 11.30, marking an increase of 1.81.
For PBT Margin (%), as of Mar 25, the value is 9.20. This value is below the healthy minimum of 10. It has increased from 7.14 (Mar 24) to 9.20, marking an increase of 2.06.
For Net Profit Margin (%), as of Mar 25, the value is 6.75. This value is within the healthy range. It has increased from 4.81 (Mar 24) to 6.75, marking an increase of 1.94.
For NP After MI And SOA Margin (%), as of Mar 25, the value is 6.63. This value is below the healthy minimum of 8. It has increased from 4.71 (Mar 24) to 6.63, marking an increase of 1.92.
For Return on Networth / Equity (%), as of Mar 25, the value is 17.60. This value is within the healthy range. It has increased from 12.95 (Mar 24) to 17.60, marking an increase of 4.65.
For Return on Capital Employeed (%), as of Mar 25, the value is 15.32. This value is within the healthy range. It has increased from 14.97 (Mar 24) to 15.32, marking an increase of 0.35.
For Return On Assets (%), as of Mar 25, the value is 6.99. This value is within the healthy range. It has increased from 5.36 (Mar 24) to 6.99, marking an increase of 1.63.
For Long Term Debt / Equity (X), as of Mar 25, the value is 0.53. This value is within the healthy range. It has increased from 0.32 (Mar 24) to 0.53, marking an increase of 0.21.
For Total Debt / Equity (X), as of Mar 25, the value is 0.64. This value is within the healthy range. It has increased from 0.45 (Mar 24) to 0.64, marking an increase of 0.19.
For Asset Turnover Ratio (%), as of Mar 25, the value is 1.17. It has decreased from 1.22 (Mar 24) to 1.17, marking a decrease of 0.05.
For Current Ratio (X), as of Mar 25, the value is 1.53. This value is within the healthy range. It has increased from 1.13 (Mar 24) to 1.53, marking an increase of 0.40.
For Quick Ratio (X), as of Mar 25, the value is 1.43. This value is within the healthy range. It has increased from 1.03 (Mar 24) to 1.43, marking an increase of 0.40.
For Inventory Turnover Ratio (X), as of Mar 25, the value is 46.34. This value exceeds the healthy maximum of 8. It has increased from 0.00 (Mar 24) to 46.34, marking an increase of 46.34.
For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 18.89. This value is below the healthy minimum of 20. It has decreased from 24.00 (Mar 24) to 18.89, marking a decrease of 5.11.
For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 12.39. This value is below the healthy minimum of 20. It has decreased from 13.60 (Mar 24) to 12.39, marking a decrease of 1.21.
For Earning Retention Ratio (%), as of Mar 25, the value is 81.11. This value exceeds the healthy maximum of 70. It has increased from 76.00 (Mar 24) to 81.11, marking an increase of 5.11.
For Cash Earning Retention Ratio (%), as of Mar 25, the value is 87.61. This value exceeds the healthy maximum of 70. It has increased from 86.40 (Mar 24) to 87.61, marking an increase of 1.21.
For Interest Coverage Ratio (X), as of Mar 25, the value is 7.03. This value is within the healthy range. It has increased from 5.56 (Mar 24) to 7.03, marking an increase of 1.47.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 4.21. This value is within the healthy range. It has increased from 3.04 (Mar 24) to 4.21, marking an increase of 1.17.
For Enterprise Value (Cr.), as of Mar 25, the value is 99,584.27. It has increased from 93,953.52 (Mar 24) to 99,584.27, marking an increase of 5,630.75.
For EV / Net Operating Revenue (X), as of Mar 25, the value is 4.57. This value exceeds the healthy maximum of 3. It has decreased from 4.93 (Mar 24) to 4.57, marking a decrease of 0.36.
For EV / EBITDA (X), as of Mar 25, the value is 30.91. This value exceeds the healthy maximum of 15. It has decreased from 37.63 (Mar 24) to 30.91, marking a decrease of 6.72.
For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 4.37. This value exceeds the healthy maximum of 3. It has decreased from 4.79 (Mar 24) to 4.37, marking a decrease of 0.42.
For Retention Ratios (%), as of Mar 25, the value is 81.10. This value exceeds the healthy maximum of 70. It has increased from 75.99 (Mar 24) to 81.10, marking an increase of 5.11.
For Price / BV (X), as of Mar 25, the value is 11.60. This value exceeds the healthy maximum of 3. It has decreased from 13.17 (Mar 24) to 11.60, marking a decrease of 1.57.
For Price / Net Operating Revenue (X), as of Mar 25, the value is 4.37. This value exceeds the healthy maximum of 3. It has decreased from 4.79 (Mar 24) to 4.37, marking a decrease of 0.42.
For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Apollo Hospitals Enterprise Ltd as of February 11, 2026 is: ₹5,335.17

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of February 11, 2026, Apollo Hospitals Enterprise Ltd is Overvalued by 26.10% compared to the current share price ₹7,219.00

Intrinsic Value of Apollo Hospitals Enterprise Ltd as of February 11, 2026 is: ₹5,849.06

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of February 11, 2026, Apollo Hospitals Enterprise Ltd is Overvalued by 18.98% compared to the current share price ₹7,219.00

Last 5 Year EPS CAGR: 9.63%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The stock has a low average Working Capital Days of 5.17, which is a positive sign. The company has higher reserves (4,804.92 cr) compared to borrowings (4,133.46 cr), indicating strong financial stability. The company has shown consistent growth in sales (11.77 cr) and profit (219.08 cr) over the years.	The stock has a low average ROCE of 11.92%, which may not be favorable. The stock has a high average Cash Conversion Cycle of 11.33, which may not be favorable.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Apollo Hospitals Enterprise Ltd:
1. Net Profit Margin: 6.75%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 15.32% (Industry Average ROCE: 15.48%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 17.6% (Industry Average ROE: 14.81%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 4.21
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 1.43
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 57.2 (Industry average Stock P/E: 95.15)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0.64
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

Apollo Hospitals Enterprise Ltd. is a Public Limited Listed company incorporated on 05/12/1979 and has its registered office in the State of Tamil Nadu, India. Company's Corporate Identification Number(CIN) is L85110TN1979PLC008035 and registration number is 008035. Currently Company is involved in the business activities of Hospital activities. Company's Total Operating Revenue is Rs. 8202.10 Cr. and Equity Capital is Rs. 71.90 Cr. for the Year ended 31/03/2025.

INDUSTRY	ADDRESS	CONTACT
Hospitals & Medical Services	No.19, Bishop Gardens, Chennai (Madras) Tamil Nadu 600028	Contact not found

Management
Name	Position Held
Dr. Prathap C Reddy	Founder & Chairman
Mrs. Preetha Reddy	Executive Vice Chairperson
Mrs. Suneeta Reddy	Managing Director
Mrs. Sangita Reddy	Joint Managing Director
Mrs. Shobana Kamineni	Non Exe.Non Ind.Director
Mrs. V Kavitha Dutt	Independent Director
Dr. Murali Doraiswamy	Independent Director
Mrs. Rama Bijapurkar	Independent Director
Dr. Som Mittal	Independent Director
Mr. M B N Rao	Lead Independent Director

FAQ

What is the intrinsic value of Apollo Hospitals Enterprise Ltd?

Apollo Hospitals Enterprise Ltd's intrinsic value (as of 11 February 2026) is ₹5849.06 which is 18.98% lower the current market price of ₹7,219.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹1,03,794 Cr. market cap, FY2025-2026 high/low of ₹8,100/6,001, reserves of ₹9,021 Cr, and liabilities of ₹21,950 Cr.

What is the Market Cap of Apollo Hospitals Enterprise Ltd?

The Market Cap of Apollo Hospitals Enterprise Ltd is 1,03,794 Cr..

What is the current Stock Price of Apollo Hospitals Enterprise Ltd as on 11 February 2026?

The current stock price of Apollo Hospitals Enterprise Ltd as on 11 February 2026 is ₹7,219.

What is the High / Low of Apollo Hospitals Enterprise Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of Apollo Hospitals Enterprise Ltd stocks is ₹8,100/6,001.

What is the Stock P/E of Apollo Hospitals Enterprise Ltd?

The Stock P/E of Apollo Hospitals Enterprise Ltd is 57.2.

What is the Book Value of Apollo Hospitals Enterprise Ltd?

The Book Value of Apollo Hospitals Enterprise Ltd is 632.

What is the Dividend Yield of Apollo Hospitals Enterprise Ltd?

The Dividend Yield of Apollo Hospitals Enterprise Ltd is 0.26 %.

What is the ROCE of Apollo Hospitals Enterprise Ltd?

The ROCE of Apollo Hospitals Enterprise Ltd is 16.6 %.

What is the ROE of Apollo Hospitals Enterprise Ltd?

The ROE of Apollo Hospitals Enterprise Ltd is 18.4 %.

What is the Face Value of Apollo Hospitals Enterprise Ltd?

The Face Value of Apollo Hospitals Enterprise Ltd is 5.00.